ADMA
ADMA Biologics Inc
$8.17
-3.54%
2026-05-08
About ADMA Biologics Inc
ADMA Biologics, Inc., a biopharmaceutical company, develops, manufactures, and markets specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. The company operates through ADMA BioManufacturing and Plasma Collection Centers segments. The company offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primary humoral immunodeficiency (PI); ASCENIV, an IVIG product for the treatment of PI; and Nabi-HB, a human polyclonal antibody product for the treatment of acute exposure to blood containing Hepatitis B surface antigen and other listed exposures to Hepatitis B. It also develops a pipeline of plasma-derived therapeutics comprising products related to the methods of treatment and prevention of S. pneumonia infection for an immunoglobulin. In addition, the company operates source plasma collection facilities. The company sells its products through independent distributors, drug wholesalers, specialty pharmacies, and other alternate site providers. ADMA Biologics, Inc. was incorporated in 2004 and is headquartered in Ramsey, New Jersey.
Key Fundamentals
P/E Ratio
12.94
Forward P/E
6.97
EPS (TTM)
$0.68
ROE
43.3%
Revenue Growth (YoY)
15.9%
Profit Margin
32.4%
Debt/Equity
110.67
Price/Book
4.38
Beta
0.48
Market Cap
$2.04B
Avg Volume (10D)
8.6M
Recent Breakout Signals
Recent Price Range (60 Days)
60D High
$17.16
60D Low
$7.21
Avg Volume
6.7M
Latest Close
$8.17
Get breakout alerts for ADMA
Sign up for Breakout Scanner to receive daily notifications when ADMA triggers breakout signals. Build custom AI screeners and backtest strategies.
Start Free Trial7-day free trial. No card required.
ADMA Biologics Inc (ADMA) is listed on the NASDAQ (NASDAQ). Breakout Scanner monitors ADMA daily for breakout patterns including long-term ceiling breakouts, momentum breakouts, and near-breakout watch setups. ADMA operates in the Healthcare sector within the Biotechnology industry. Data is provided for informational purposes only and does not constitute financial advice.